(Q42245961)

English

Efficacy of (E)-5-(2-bromovinyl)-2′-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice

scientific article published on October 1, 1982

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Efficacy of (E)-5-(2-bromovinyl)-2′-deoxyuridine against different herpes simplex virus strains in cell culture and against experimental herpes encephalitis in mice (English)

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

author name string

J. Reefschläger

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

P. Wutzler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

K. D. Thiel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

D. Bärwolff

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

P. Langen

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

M. Sprössig

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

H. A. Rosenthal

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6295273

19 September 2023

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 1982

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0166354282900493?httpAccept=text/xml

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

https://api.elsevier.com/content/article/PII:0166354282900493?httpAccept=text/plain

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Antiviral Research

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

255-265

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication

4

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Growth Inhibition by Acycloguanosine of Herpesviruses Isolated from Human Infections

5

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Effect of treatment with 5-ethyl-2'-deoxyuridine on herpes simplex virus encephalitis in normal and immunosuppressed mice

6

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Pharmacokinetics of E -5-(2-Bromovinyl)-2′-Deoxyuridine in Mice

8

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Comparative Efficacy of Antiherpes Drugs against Different Strains of Herpes Simplex Virus

9

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster

11

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds

14

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

E-5-(2-Bromovinyl)-2'-Deoxyuridine vs. Interferon in the Systemic Treatment of Infection with Herpes Simplex Virus of Athymic Nude Mice

15

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Differential effects of E-5-(2-bromovinyl)-2'-deoxyuridine on infections with herpes simplex virus type 1 and type 2 in hairless mice

16

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice

17

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Inhibition of herpes simplex virus replication by araT

19

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent

21

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice

22

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil

23

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils

24

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

(E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis

26

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis

27

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Preliminary results of oral BVDU treatment of herpes zoster ophthalmicus

28

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Differential effect of arabinofuranosylthymine of the replication of human herpesviruses

29

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Therapy of Experimental Herpes Simplex Encephalitis with Aciclovir in Mice

30

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Efficiency and selectivity of (E)-5-(2-bromovinyl)-2′-deoxyuridine and some other 5-substituted 2′-deoxypyrimidine nucleosides as anti-herpes agents

31

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Synthesis and antiherpesviral activity of 5-C-substituted uracil nucleosides

33

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides

39

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Bovid herpesvirus type-1 (infectious bovine rhinotracheitis virus)-induced thymidine kinase

40

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Herpesvirus-induced autoantibodies in animals (author's transl)

41

1 reference

10.1016/0166-3542(82)90049-3

https://api.crossref.org/works/10.1016/0166-3542(82)90049-3

19 September 2023

Identifiers

10.1016/0166-3542(82)90049-3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42245961&oldid=1977618104"